Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice
Authors
Keywords
-
Journal
CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-05-15
DOI
10.1002/cncr.32175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- What Do “None,” “Mild,” “Moderate,” “Severe,” and “Very Severe” Mean to Patients With Cancer? Content Validity of PRO-CTCAE™ Response Scales
- (2018) Thomas M. Atkinson et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
- (2017) Ethan Basch et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review
- (2017) Donna R. Rivera et al. JNCI-Journal of the National Cancer Institute
- Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30
- (2017) Hanna Bandos et al. JNCI-Journal of the National Cancer Institute
- Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial
- (2017) Akiko Hanai et al. JNCI-Journal of the National Cancer Institute
- The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice
- (2017) Natalie B. Simon et al. QUALITY OF LIFE RESEARCH
- Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer
- (2017) Su Jeong Song et al. SUPPORTIVE CARE IN CANCER
- Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial
- (2017) Ian R. Kleckner et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review
- (2017) Donna R. Rivera et al. JNCI-Journal of the National Cancer Institute
- Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30
- (2017) Hanna Bandos et al. JNCI-Journal of the National Cancer Institute
- Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial
- (2017) Akiko Hanai et al. JNCI-Journal of the National Cancer Institute
- Physical performance measures for predicting outcome in cancer patients: a systematic review
- (2016) Norbert M. Verweij et al. ACTA ONCOLOGICA
- Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis
- (2016) Rita Pavasini et al. BMC Medicine
- A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis
- (2016) Filipa Fontes et al. BREAST
- Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
- (2016) Ting Bao et al. BREAST CANCER RESEARCH AND TREATMENT
- Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
- (2016) Ethan Basch et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of toxicity profile and tolerability between two standard of care paclitaxel-based adjuvant chemotherapy regimens in breast cancer
- (2016) Mohamed Alsharedi et al. MEDICAL ONCOLOGY
- Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment
- (2016) Noah R. Zanville et al. SUPPORTIVE CARE IN CANCER
- Docetaxel-induced neuropathy: A pharmacogenetic case-control study of 150 women with early-stage breast cancer
- (2015) Lise Eckhoff et al. ACTA ONCOLOGICA
- Neurological complications of breast cancer: A prospective cohort study
- (2015) Susana Pereira et al. BREAST
- Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors
- (2015) L. Eckhoff et al. EUROPEAN JOURNAL OF CANCER
- Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study
- (2015) Susana Pereira et al. SUPPORTIVE CARE IN CANCER
- Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
- (2015) Amylou C. Dueck et al. JAMA Oncology
- Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy
- (2014) K S Courneya et al. BRITISH JOURNAL OF CANCER
- Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials
- (2014) B. B. Reeve et al. JNCI-Journal of the National Cancer Institute
- Effect of Cytotoxic Chemotherapy on Markers of Molecular Age in Patients With Breast Cancer
- (2014) Hanna K. Sanoff et al. JNCI-Journal of the National Cancer Institute
- Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
- (2014) E. Basch et al. JNCI-Journal of the National Cancer Institute
- Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience
- (2014) Bhavana Bhatnagar et al. SpringerPlus
- Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
- (2013) Jennifer L. Hay et al. QUALITY OF LIFE RESEARCH
- Impact of Chemotherapy-Induced Peripheral Neuropathy on Treatment Delivery in Nonmetastatic Breast Cancer
- (2013) Rebecca M. Speck et al. Journal of Oncology Practice
- Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer
- (2012) Bryan P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Relationship status and quality moderate daily pain-related changes in physical disability, affect, and cognitions in women with chronic pain
- (2012) Shannon Stark Taylor et al. PAIN
- Pain and Functioning of Rheumatoid Arthritis Patients Based on Marital Status: Is a Distressed Marriage Preferable to No Marriage?
- (2010) Jennifer Barsky Reese et al. JOURNAL OF PAIN
- Chemotherapy-Induced Peripheral Neuropathy as a Predictor of Neuropathic Pain in Breast Cancer Patients Previously Treated With Paclitaxel
- (2009) Cielito C. Reyes-Gibby et al. JOURNAL OF PAIN
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
- (2009) Kojiro Shimozuma et al. SUPPORTIVE CARE IN CANCER
- Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
- (2008) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
- (2007) Michele De Laurentiis et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started